Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00434031
Status:
WITHDRAWN
Last Update Posted:
2012-07-30
First Post:
2007-02-09
Brief Title:
CETRA Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
Sponsor:
National Cancer Institute Naples
Organization:
National Cancer Institute Naples
Organization Data
Organization:
National Cancer Institute Naples
Class:
OTHER
Study ID:
CETRA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute Naples
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None